28 / 31
Sensor100
March 2017
28
MovingToward Diabetes SolutionsThatThink for
Themselves
One of the exiting things about the race for the artificial pancreas (AP) is that it isn’t
on one path—experts in academia and the commercial sector are pursuing many dif-
ferent solutions at once, which advocates for people with diabetes say is a good thing.
Any solution will require data-driven technology to “think” in place of a pancreas that
fails to do its job of delivering the right amount of insulin at the right time. But what
will drive that technology? More than 40 studies had contributed to the fine-tuning
of algorithms over the past decade by 2014, according a review reported in Diabetes
Care, and more have occurred since.
A company called AspireVentures, which specializes in predictive technology, is tak-
ing a different approach. It has created an adaptive artificial intelligence (AI) platform
known as A2I, and through its subsidiary Tempo Health, developed a noninvasive sys-
tem—dubbed Rhythm—to customize glucose monitoring.
Rhythm takes multiple algorithms and creates one that fits the individual patient.And
a small study that Tempo Health recently presented shows that the system does a bet-
ter job than one of the best clinical settings in the world, Diabeter in the Netherlands,
which Medtronic purchased in 2015.
Reported by:
AJMC.comMarch 13